Nov 10, 2025 08:30AM
May 23, 2025 08:30AM
Nov 19, 2024 08:30AM
Nov 4, 2024 08:30AM
Oct 30, 2023 08:30AM
May 24, 2023 08:30AM
Nov 9, 2022 08:30AM Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
Nov 9, 2022 08:30AM
Sep 23, 2022 08:30AM
Sep 23, 2022 08:30AM
Apr 12, 2022 08:30AM
Apr 12, 2022 08:30AM
Nov 12, 2021 08:30AM
Nov 12, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
Oct 8, 2021 07:38AM
Jul 1, 2021 09:18AM
Jun 21, 2021 07:40AM
May 20, 2021 08:30AM
May 20, 2021 08:30AM
Nov 12, 2020 08:30AM
Nov 12, 2020 08:30AM Allogene Therapeutics Announces November and December 2020 Virtual Investor Conference Participation
Oct 1, 2020 08:30AM
Oct 1, 2020 08:30AM
Jun 3, 2020 08:30AM
Jun 3, 2020 08:30AM
Jun 2, 2020 05:50AM
Jun 1, 2020 09:05PM
Jun 1, 2020 09:05PM Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
Jun 1, 2020 06:31AM
Jun 1, 2020 06:30AM
Jun 1, 2020 06:30AM
Nov 11, 2019 08:30AM
Nov 11, 2019 08:30AM
May 29, 2019 08:30AM
May 29, 2019 08:30AM Allogene Therapeutics Announces June 2019 Investor Conference Schedule
Apr 3, 2019 04:30PM
Apr 3, 2019 04:30PM
Nov 5, 2018 08:00AM
Nov 5, 2018 08:00AM
Nov 5, 2018 04:11AM
Oct 15, 2018 04:30PM
Oct 11, 2018 11:13AM Allogene Therapeutics (ALLO) IPO Opens Up 22%

69,742 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All